BioSpace News Archive

Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), announces that Alimera Sciences Europe Limited, its Ireland-based European subsidiary, has been granted reimbursement for ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg sustained release intravitreal implant for non-infectious uveitis affecting the posterior segment in Portugal.

BD (Becton, Dickinson and Company) today announced a collaboration agreement with Labcorp.

NanoViricides, Inc. provides further details on its rapid drug development strategy for Monkeypox virus.

Novaliq, today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for CyclASol® (cyclosporine ophthalmic solution), a proposed novel treatment for the signs and symptoms of dry eye disease (DED).

Fusion Pharmaceuticals Inc. today announced financial results for the second quarter ended June 30, 2022 and provided an update on clinical and corporate developments.

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced financial results for the three and six months ended June 30, 2022.

Nevro Corp. announced today that it is participating in the following investor conferences.

Novanta Inc. today reported financial results for the second quarter 2022.

ADC Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates.

TransMed7, LLC announced today that the first clinical cases of the final commercial production version of the Sparrow device (a member of the new SpeedBird™ family of vacuum-assisted, Single Insertion / Multiple Collection (SIMC®) Breast Biopsy devices) were successfully performed by Dr. Edgar Staren, a distinguished surgeon and former President of the American Society of Breast Surgeons (ASBrS).